RxDoctor Payments Data

Michelle Smith

Family · Jackson, MSNPI 1730883661

Payments from drug & device makers

$7,170in general payments, 2019–2025

Across 400 payments — averaging $17.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$2K
  • AbbVie$1K
  • UCB, Inc.$840
  • Novartis$830
  • Johnson & Johnson$555
  • Mallinckrodt Hospital Products Inc.$406
  • plus $2K from 15 others

What the payments were for

  • Food & beverage$7,170100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,170 in reported general payments places this provider in the 95th percentile of 3,007 family providers in Mississippi.

See all family providers in Mississippi

Medicare billing

Part B allowed, 2024
$204,790
Medicare patients
290
Services billed
15,411

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Enbrel SureclickEtanercept99$721,695
Humira(Cf) PenAdalimumab30$285,478
Cosentyx Sensoready (2 Pens)Secukinumab15$113,802
RinvoqUpadacitinib15$98,178
RemicadeInfliximab12$82,697
BenlystaBelimumab13$63,153
ProliaDenosumab19$32,111
Hydroxychloroquine Sulfate476$13,811
MethotrexateMethotrexate Sodium413$7,337
Celecoxib127$1,899
Prednisone279$1,789
Duloxetine Hcl58$1,629
Diclofenac Sodium95$1,457
Leflunomide42$1,139
Gabapentin87$768

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRinvoq$1,294$98,17815 claims
Johnson & JohnsonRemicade$555$82,69712 claims
AmgenProlia$1,540$32,11119 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,007 family providers in Mississippi.

Other family in Jackson

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →